AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2024
Apr 3, 2024
32180_dirs_2024-04-02_219067de-f4a1-4d46-b148-7c12ddc28bc3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2024-04-02
Reporting Person: Gallagher Neil (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-04-02 | Stock Option (Right to Buy) | $9.23 | A | 74000 | Acquired | 2034-04-01 | Common Stock (74000) | Direct |
Footnotes
F1: Stock options vest in 36 equal monthly installments starting one month after grant date of April 2, 2024.